Kathryn Romano - 26 Feb 2022 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Role: Chief Accounting Officer
Signature: /s/ Kathryn Romano
Issuer symbol: KRYS
Transactions as of: 26 Feb 2022
Net transactions value: -$92,000
Form type: 4
Filing time: 01 Mar 2022, 20:25:29 UTC
Next filing: 28 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRYS	Common Stock	Tax liability	$92,000	-1,472	-7.5%	$62.50	18,128	26 Feb 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KRYS	Stock Option (Right to Buy)	Award	$0	+50,000		$0.000000	50,000	28 Feb 2022	Common Stock	50,000	$63.55	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents tax withholding upon the vesting of 4,900 shares of restricted stock on February 26, 2022.
F2	The closing price on February 25, 2022 of the Company's common stock on NASDAQ.
F3	The option vests in four equal annual installments beginning on February 28, 2023.